Researchers from National Cancer Institute (NCI) Describe Findings in Monoclonal Antibodies (In Silico Re-optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure-response Simulation)

  • William Figg

Press/Media

Period28 Mar 2023

Media coverage

1

Media coverage

  • TitleResearchers from National Cancer Institute (NCI) Describe Findings in Monoclonal Antibodies (In Silico Re-optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure-response Simulation)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date28/03/23
    PersonsWilliam Figg
View all 1
View less

Related content